• Activity INFORMATION

  Overview

  It has been over 40 years since “HIV” and “AIDS” became commonplace words for both the healthcare profession and the general population. Fortunately, in the 1990s, drugs with different mechanisms of action were developed to take HIV from a “death sentence” to a manageable disease. Today, the focus for affected individuals has shifted to medication adherence for these robust therapies, as well as disease prevention. PrEP (Pre-Exposure Prophylaxis) is a priority now that we have preventative agents that are more patient-friendly, to help bring an end to the spread of this disease. Join Professor Pete for a comprehensive discussion of the history, treatment, and preventative strategies for HIV and AIDS as patient care moves into a new era.

  This course meets the FL requirement of 1.0 board-approved contact hour on the topic of HIV/AIDS.

  
  

  Handouts

  • Slide Document :   23209H02_2pp.pdf Download

  • Slide Document :   23209H02_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25

  Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system

  Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy

  Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection

  Recognize the epidemiology, prevention, and appropriate clinical management of HIV

  Identify related infections associated with HIV, including tuberculosis (TB)

  Pharmacy Technician

  Recognize the epidemiology, prevention, and appropriate clinical management of HIV

  Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection

  Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  Identify related infections associated with HIV, including tuberculosis (TB)

  Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system

  State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25

  Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy

  Nurse

  Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy

  Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection

  Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system

  Identify related infections associated with HIV, including tuberculosis (TB)

  Recognize the epidemiology, prevention, and appropriate clinical management of HIV

  Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1160634

  Universal Activity Number

  Pharmacist 0798-0000-23-209-H02-P
  Pharmacy Technician 0798-0000-23-209-H02-T
  Nurse 0798-0000-23-209-H02-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Peter  Kreckel, RPh Retired Adjunct Assistant Professor, Saint Francis University

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).